Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion
1 Parkinson and Movement Disorders Unit, Study Center on Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padova, Italy. feder.garri@gmail.com.
2 Parkinson Institute, ASST G. Pini-CTO, Milan, Italy. feder.garri@gmail.com.
3 Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy. feder.garri@gmail.com.
4 Gastroenterology/Multivisceral Transplant Unit, Department of Surgery, Oncology, and Gastroenterology, Study Center on Neurodegeneration (CESNE), Padova University, Padova, Italy.
5 Parkinson and Movement Disorders Unit, Study Center on Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padova, Italy.
6 Department of General Psychology, Study Center on Neurodegeneration (CESNE), Padova University, Padova, Italy.
7 Parkinson Institute, ASST G. Pini-CTO, Milan, Italy.
8 Fondazione Grigioni per il Morbo di Parkinson, Milan, Italy.
9 Parkinson and Movement Disorders Unit, Study Center on Neurodegeneration (CESNE), Department of Neuroscience, University of Padua, Padova, Italy. angelo.antonini@unipd.it.